1. Academic Validation
  2. Agonistic anti-CD40 enhances the CD8+ T cell response during vesicular stomatitis virus infection

Agonistic anti-CD40 enhances the CD8+ T cell response during vesicular stomatitis virus infection

  • PLoS One. 2014 Aug 28;9(8):e106060. doi: 10.1371/journal.pone.0106060.
Julianne M Zickovich 1 Susan I Meyer 1 Hideo Yagita 2 Joshua J Obar 1
Affiliations

Affiliations

  • 1 Department of Microbiology & Immunology, Montana State University, Bozeman, Montana, United States of America.
  • 2 Department of Immunology, Juntendo University, School of Medicine, Toyko, Japan.
Abstract

Intracellular pathogens are capable of inducing vigorous CD8+ T cell responses. However, we do not entirely understand the factors driving the generation of large pools of highly protective memory CD8+ T cells. Here, we studied the generation of endogenous ovalbumin-specific memory CD8+ T cells following Infection with recombinant vesicular stomatitis virus (VSV) and Listeria monocytogenes (LM). VSV Infection resulted in the generation of a large ovalbumin-specific memory CD8+ T cell population, which provided minimal protective immunity that waned with time. In contrast, the CD8+ T cell population of LM-ova provided protective immunity and remained stable with time. Agonistic CD40 stimulation during CD8+ T cell priming in response to VSV Infection enabled the resultant memory CD8+ T cell population to provide strong protective immunity against secondary Infection. Enhanced protective immunity by agonistic anti-CD40 was dependent on CD70. Agonistic anti-CD40 not only enhanced the size of the resultant memory CD8+ T cell population, but enhanced their polyfunctionality and sensitivity to antigen. Our data suggest that immunomodulation of CD40 signaling may be a key Adjuvant to enhance CD8+ T cell response during development of VSV vaccine strategies.

Figures
Products